Biogen bolsters ischaemic stroke pipeline with thrombolytic from TMSBiogen has licensed a new drug from Japanese biotech TMS that it hopes could provide a big advance Share XBiogen bolsters ischaemic stroke pipeline with thrombolytic from TMShttps://pharmaphorum.com/news/biogen-bolsters-ischaemic-stroke-pipeline-with-thrombolytic-from-tms/
